Cargando…
Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
Object: To identify genes of prognostic value which associated with tumor microenvironment (TME) in acute myeloid leukemia (AML). Methods and Materials: Level 3 AML patients gene transcriptome profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Clinical characteristics and surviva...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990132/ https://www.ncbi.nlm.nih.gov/pubmed/32039005 http://dx.doi.org/10.3389/fonc.2019.01509 |
_version_ | 1783492481071972352 |
---|---|
author | Ni, Jie Wu, Yang Qi, Feng Li, Xiao Yu, Shaorong Liu, Siwen Feng, Jifeng Zheng, Yuxiao |
author_facet | Ni, Jie Wu, Yang Qi, Feng Li, Xiao Yu, Shaorong Liu, Siwen Feng, Jifeng Zheng, Yuxiao |
author_sort | Ni, Jie |
collection | PubMed |
description | Object: To identify genes of prognostic value which associated with tumor microenvironment (TME) in acute myeloid leukemia (AML). Methods and Materials: Level 3 AML patients gene transcriptome profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Clinical characteristics and survival data were extracted from the Genomic Data Commons (GDC) tool. Then, limma package was utilized for normalization processing. ESTIMATE algorithm was used for calculating immune, stromal and ESTIMATE scores. We examined the distribution of these scores in Cancer and Acute Leukemia Group B (CALGB) cytogenetics risk category. Kaplan-Meier (K-M) curves were used to evaluate the relationship between immune scores, stromal scores, ESTIMATE scores and overall survival. We performed clustering analysis and screened differential expressed genes (DEGs) by using heatmaps, volcano plots and Venn plots. After pathway enrichment analysis and gene set enrichment analysis (GESA), protein-protein interaction (PPI) network was constructed and hub genes were screened. We explore the prognostic value of hub genes by calculating risk scores (RS) and processing survival analysis. Finally, we verified the expression level, association of overall survival and gene interactions of hub genes in the Vizome database. Results: We enrolled 173 AML samples from TCGA database in our study. Higher immune score was associated with higher risk rating in CALGB cytogenetics risk category (P = 0.0396) and worse overall survival outcomes (P = 0.0224). In Venn plots, 827 intersect genes were screened with differential analysis. Functional enrichment clustering analysis revealed a significant association between intersect genes and the immune response. After PPI network, 18 TME-related hub genes were identified. RS was calculated and the survival analysis results revealed that high RS was related with poor overall survival (P < 0.0001). Besides, the survival receiver operating characteristic curve (ROC) showed superior predictive accuracy (area under the curve = 0.725). Finally, the heatmap from Vizome database demonstrated that 18 hub genes showed high expression in patient samples. Conclusion: We identified 18 TME-related genes which significantly associated with overall survival in AML patients from TCGA database. |
format | Online Article Text |
id | pubmed-6990132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69901322020-02-07 Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia Ni, Jie Wu, Yang Qi, Feng Li, Xiao Yu, Shaorong Liu, Siwen Feng, Jifeng Zheng, Yuxiao Front Oncol Oncology Object: To identify genes of prognostic value which associated with tumor microenvironment (TME) in acute myeloid leukemia (AML). Methods and Materials: Level 3 AML patients gene transcriptome profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Clinical characteristics and survival data were extracted from the Genomic Data Commons (GDC) tool. Then, limma package was utilized for normalization processing. ESTIMATE algorithm was used for calculating immune, stromal and ESTIMATE scores. We examined the distribution of these scores in Cancer and Acute Leukemia Group B (CALGB) cytogenetics risk category. Kaplan-Meier (K-M) curves were used to evaluate the relationship between immune scores, stromal scores, ESTIMATE scores and overall survival. We performed clustering analysis and screened differential expressed genes (DEGs) by using heatmaps, volcano plots and Venn plots. After pathway enrichment analysis and gene set enrichment analysis (GESA), protein-protein interaction (PPI) network was constructed and hub genes were screened. We explore the prognostic value of hub genes by calculating risk scores (RS) and processing survival analysis. Finally, we verified the expression level, association of overall survival and gene interactions of hub genes in the Vizome database. Results: We enrolled 173 AML samples from TCGA database in our study. Higher immune score was associated with higher risk rating in CALGB cytogenetics risk category (P = 0.0396) and worse overall survival outcomes (P = 0.0224). In Venn plots, 827 intersect genes were screened with differential analysis. Functional enrichment clustering analysis revealed a significant association between intersect genes and the immune response. After PPI network, 18 TME-related hub genes were identified. RS was calculated and the survival analysis results revealed that high RS was related with poor overall survival (P < 0.0001). Besides, the survival receiver operating characteristic curve (ROC) showed superior predictive accuracy (area under the curve = 0.725). Finally, the heatmap from Vizome database demonstrated that 18 hub genes showed high expression in patient samples. Conclusion: We identified 18 TME-related genes which significantly associated with overall survival in AML patients from TCGA database. Frontiers Media S.A. 2020-01-21 /pmc/articles/PMC6990132/ /pubmed/32039005 http://dx.doi.org/10.3389/fonc.2019.01509 Text en Copyright © 2020 Ni, Wu, Qi, Li, Yu, Liu, Feng and Zheng. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ni, Jie Wu, Yang Qi, Feng Li, Xiao Yu, Shaorong Liu, Siwen Feng, Jifeng Zheng, Yuxiao Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia |
title | Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia |
title_full | Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia |
title_fullStr | Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia |
title_full_unstemmed | Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia |
title_short | Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia |
title_sort | screening the cancer genome atlas database for genes of prognostic value in acute myeloid leukemia |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990132/ https://www.ncbi.nlm.nih.gov/pubmed/32039005 http://dx.doi.org/10.3389/fonc.2019.01509 |
work_keys_str_mv | AT nijie screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia AT wuyang screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia AT qifeng screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia AT lixiao screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia AT yushaorong screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia AT liusiwen screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia AT fengjifeng screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia AT zhengyuxiao screeningthecancergenomeatlasdatabaseforgenesofprognosticvalueinacutemyeloidleukemia |